Bayesian Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Bayesian Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-22,411	Closed	-$346K	–	1128
2023 Q1	$346K	Buy	+22,411	New	+$374K	0.04%	477
2022 Q4	–	Sell	-20,100	Closed	-$372K	–	1085
2022 Q3	$372K	Buy	20,100 +3,300	+20%	+$51.8K	0.08%	352
2022 Q2	$221K	Sell	16,800 -25,100	-60%	-$277K	0.04%	590
2022 Q1	$388K	Buy	+41,900	New	+$356K	0.06%	449

Other funds holding DCPH

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bayesian Capital Management's DCPH Position: Q2 2023 in Review

Bayesian Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2023, closing a stake of 22,411 shares — an estimated $346K sold.

Bayesian Capital Management first reported a position in DCPH in Q1 2022 and held it in 4 quarters. The position peaked at $388K in Q1 2022. 145 funds tracked by Wall St. Rank hold DCPH as of Q2 2023.

Bayesian Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Bayesian Capital Management sold 22,411 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $346K.
Bayesian Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Bayesian Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $388K in Q1 2022.
145 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Bayesian Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.